|
GB2377218A
(en)
*
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
|
AU2005305675B2
(en)
|
2004-11-16 |
2012-12-13 |
Jazz Pharmaceuticals Operations Uk Limited |
New use for cannabinoid
|
|
GB0425248D0
(en)
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
GB2460672B
(en)
*
|
2008-06-04 |
2012-01-04 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB2494461A
(en)
*
|
2011-09-12 |
2013-03-13 |
Gw Pharma Ltd |
Phytocannabinoids for use in the treatment of invasive cancers or metastases
|
|
GB2495118B
(en)
*
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB201117956D0
(en)
*
|
2011-10-18 |
2011-11-30 |
Otsuka Pharma Co Ltd |
Phytocannabinoids for use in the treatment of breast cancer
|
|
US9776014B2
(en)
|
2012-05-03 |
2017-10-03 |
Magdent Ltd. |
Bone enhancement device and method
|
|
CA2895805A1
(en)
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
JP6581509B2
(ja)
|
2013-02-28 |
2019-09-25 |
ティーウィノット テクノロジーズ リミテッド |
化合物を合成する化学工学プロセス及び装置
|
|
EP2968259B1
(en)
|
2013-03-14 |
2022-09-14 |
SC Laboratories Inc. |
Bioactive concentrates and uses thereof
|
|
WO2014145490A2
(en)
|
2013-03-15 |
2014-09-18 |
Biotech Institute, Llc |
Breeding, production, processing and use of specialty cannabis
|
|
US10441617B2
(en)
|
2013-03-15 |
2019-10-15 |
Biotech Institute, Llc |
Breeding, production, processing and use of medical cannabis
|
|
GB2513167B
(en)
|
2013-04-18 |
2016-03-02 |
Otsuka Pharma Co Ltd |
Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
|
|
GB2516814B
(en)
*
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
GB2515312A
(en)
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
US10774288B2
(en)
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
US20160279073A1
(en)
*
|
2013-10-31 |
2016-09-29 |
Full Spectrum Laboratories, Ltd. |
Terpene and cannabinoid formulations
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
GB2527590A
(en)
*
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
CA2992923C
(en)
|
2014-07-21 |
2021-06-29 |
Pharmaceutical Productions, Inc. |
Solid dosage form composition for buccal and sublingual administration of cannabinoids
|
|
AU2015308136B2
(en)
|
2014-08-25 |
2020-07-09 |
Teewinot Technologies Limited |
Apparatus and methods for the simultaneous production of cannabinoid compounds
|
|
WO2016044370A1
(en)
|
2014-09-16 |
2016-03-24 |
India Globalization Capital, Inc. |
Cannabinoid composition and method for treating pain
|
|
US9844518B2
(en)
|
2014-09-30 |
2017-12-19 |
MJAR Holdings, LLC |
Methods of growing cannabaceae plants using artificial lighting
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
CA3135893C
(en)
*
|
2014-10-21 |
2023-11-14 |
United Cannabis Corp. |
Cannabis extracts and methods of preparing and using same
|
|
CN104277917B
(zh)
*
|
2014-10-24 |
2018-02-09 |
汉康(云南)生物科技有限公司 |
一种富含大麻二酚的工业大麻精油提取方法及其提取设备
|
|
US10502750B2
(en)
|
2014-12-23 |
2019-12-10 |
Biotech Institute, Llc |
Reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
|
|
WO2016118391A1
(en)
|
2015-01-25 |
2016-07-28 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
CA3012599A1
(en)
|
2015-01-26 |
2016-08-04 |
Matthew W. Giese |
Systems, apparatuses, and methods for classification
|
|
CA2974292C
(en)
|
2015-01-31 |
2024-04-16 |
Constance Therapeutics, Inc. |
Methods for preparation of cannabis oil extracts and compositions
|
|
US10238745B2
(en)
|
2015-01-31 |
2019-03-26 |
Constance Therapeutics, Inc. |
Cannabinoid composition and products including α-tocopherol
|
|
US20160250270A1
(en)
|
2015-02-27 |
2016-09-01 |
Ebbu, LLC |
Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
|
|
CN107405314A
(zh)
*
|
2015-02-27 |
2017-11-28 |
埃布公司 |
包含纯化的大麻素与至少一种类黄酮、萜或矿物质的组合的组合物
|
|
US12303541B2
(en)
|
2015-04-01 |
2025-05-20 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
|
JP2018515608A
(ja)
*
|
2015-05-07 |
2018-06-14 |
シャルダン, マーク アンドリューSCIALDONE, Mark Andrew |
カンナビスオイルの水素化
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
EP3319446A4
(en)
*
|
2015-07-06 |
2019-07-03 |
Cg- Bio Genomics, Inc. |
Healthful supplements
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10596159B2
(en)
|
2015-08-12 |
2020-03-24 |
India Globalization Capital, Inc. |
Method and composition for treating cachexia and eating disorders
|
|
EP3380096A4
(en)
*
|
2015-11-24 |
2019-10-23 |
Constance Therapeutics, Inc. |
CANNABIS OIL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
|
|
MX421795B
(es)
*
|
2016-03-18 |
2025-03-14 |
Christopher Brian Reid |
Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
WO2017218629A1
(en)
|
2016-06-15 |
2017-12-21 |
India Globalization Capital, Inc. |
Method and composition for treating seizure disorders
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
AU2017307644B2
(en)
*
|
2016-08-03 |
2019-06-20 |
Zelira Therapeutics Operations Pty Ltd |
Cannabis composition
|
|
WO2018023166A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Zelda Therapeutics Operations Pty Ltd |
Cannabis composition
|
|
KR20190035791A
(ko)
*
|
2016-08-03 |
2019-04-03 |
젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 |
카나비스 조성물
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
US12485129B2
(en)
|
2016-08-29 |
2025-12-02 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
CA3034004C
(en)
|
2016-08-29 |
2021-08-03 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
AU2018227544A1
(en)
*
|
2017-03-01 |
2019-08-29 |
Canopy Growth Corporation |
Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
|
|
CN110621312A
(zh)
*
|
2017-03-05 |
2019-12-27 |
以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 |
用于治疗癌症的组合物和方法
|
|
WO2018205038A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Tetra Bio-Pharma Inc. |
Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling
|
|
CN110913839A
(zh)
*
|
2017-05-22 |
2020-03-24 |
Gbs全球生物制药公司 |
靶向trpv1的含月桂烯和大麻素的组合物
|
|
AU2018286647B2
(en)
|
2017-06-19 |
2024-03-28 |
Zelira Therapeutics Operations Pty Ltd |
Sleep disorder compositions and treatments thereof
|
|
DK3509638T3
(da)
|
2017-06-20 |
2022-04-11 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Præparater med cannabidiolsyreestere og anvendelser deraf
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
IL304777B1
(en)
*
|
2017-06-28 |
2026-02-01 |
Buzzelet Development And Technologies Ltd |
Terpene-enriched cannabinoid products for women's health
|
|
CA3079537A1
(en)
*
|
2017-09-02 |
2019-03-07 |
Scientific Holdings, Llc |
Tetrahydrocannabinol modulators
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
CN108204786A
(zh)
*
|
2018-01-15 |
2018-06-26 |
武汉盛硕电子有限公司 |
一种基于手机模块的北斗测量系统
|
|
US10688191B2
(en)
|
2018-01-19 |
2020-06-23 |
Hr Biomed, Llc |
Delivery of a chemotherapy agent across the blood-brain barrier
|
|
CA3096287A1
(en)
*
|
2018-01-22 |
2019-07-25 |
Pascal Biosciences Inc. |
Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells
|
|
BR112020016074A2
(pt)
|
2018-02-08 |
2020-12-08 |
Neonc Technologies, Inc |
Métodos de permeabilização da barreira hematoencefálica
|
|
KR20190098649A
(ko)
|
2018-02-14 |
2019-08-22 |
(주)카이언바이오텍 |
칸나비디올 추출물을 함유하는 대장암 예방 또는 치료용 약학 조성물
|
|
KR102041875B1
(ko)
|
2018-02-14 |
2019-11-08 |
(주)카이언바이오텍 |
대마로부터 추출된 칸나비디올 추출물 및 트레일을 함유하는 대장암 예방 또는 치료용 약학 조성물
|
|
JP7293561B2
(ja)
*
|
2018-02-20 |
2023-06-20 |
マイエムディー ファーマスーティカルズ、インコーポレイテッド |
薬物中毒および他の障害の治療のための遺伝子組み換え大麻植物および組み換えカンナビノイド化合物
|
|
MX2020010284A
(es)
|
2018-03-30 |
2021-02-18 |
India Globalization Capital Inc |
Método y composición para el tratamiento de los trastornos del snc.
|
|
EP3773722A1
(en)
|
2018-04-04 |
2021-02-17 |
Jay Pharma Inc. |
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer
|
|
BR112020020850A2
(pt)
|
2018-04-09 |
2021-01-19 |
Ellevet Sciences |
Extrato de cânhamo para tratamento da dor em animais
|
|
WO2019227167A1
(en)
*
|
2018-06-01 |
2019-12-05 |
The University Of Sydney |
Compositions and treatments
|
|
WO2020012315A1
(en)
*
|
2018-07-08 |
2020-01-16 |
Buzzelet Development And Technologies Ltd. |
Terpene-enriched cannabinoid composition for treatment of male subjects
|
|
EP3666765A1
(en)
*
|
2018-12-11 |
2020-06-17 |
Emerald Health Biotechnology España,S.L.U. |
Chromenic phytocannabinoids, their synthesis and use in treatment or prevention of disease
|
|
CA3123773A1
(en)
*
|
2018-12-12 |
2020-06-18 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl)
|
|
CA3128054A1
(en)
*
|
2019-01-31 |
2020-08-06 |
Cava Healthcare Inc. |
Compounds for increasing mhc-i expression and modulating histone deacetylase activity
|
|
NL2022614B1
(en)
*
|
2019-02-21 |
2020-08-31 |
Patrick Alexander Unger |
Pharmaceutical, phyto-cannabinoid based compositions
|
|
EP3937925A1
(en)
|
2019-03-12 |
2022-01-19 |
EPM (IP), Inc. |
Cannabinoid acid ester compositions and uses thereof
|
|
EP3946307A4
(en)
*
|
2019-04-02 |
2022-12-14 |
Ulagaraj Selvaraj |
SOLID NANOPARTICLE FORMULATION OF WATER-INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD MATURATION AND IMMEDIATE DRUG RELEASE AFTER INTRAVENOUS ADMINISTRATION
|
|
US12178797B2
(en)
|
2019-05-03 |
2024-12-31 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
US12220396B2
(en)
|
2019-05-03 |
2025-02-11 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
KR102445087B1
(ko)
*
|
2019-05-03 |
2022-09-20 |
자이우스 라이프 사이언시스 아이엔씨. |
통증 관리용 제형
|
|
AU2020275513A1
(en)
*
|
2019-05-16 |
2021-12-16 |
Ramot At Tel-Aviv University Ltd. |
Cannabinoids and uses thereof
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB2588576A
(en)
|
2019-08-27 |
2021-05-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
CN111184710A
(zh)
*
|
2020-03-02 |
2020-05-22 |
福建省中科生物股份有限公司 |
一种环酚的应用和制备方法
|
|
WO2021219903A1
(es)
*
|
2020-04-29 |
2021-11-04 |
Emerald Health Biotechnology España S.L. |
Cannabinoides para uso en la supresión de células madre cancerosas
|
|
EP3912485A1
(en)
|
2020-05-18 |
2021-11-24 |
Del-Vis Sp. z o.o. |
Cigarette product and a method for manufacturing the product
|
|
CN111773390B
(zh)
*
|
2020-07-01 |
2021-08-20 |
南京大学 |
一种药物在制备治疗脑转移瘤及其相关疾病的药品中的应用
|
|
US20220064090A1
(en)
*
|
2020-07-10 |
2022-03-03 |
Consiglio Nazionale Delle Ricerche |
Cannabis extracts and uses thereof
|
|
GB2597321A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
CA3182869A1
(en)
*
|
2020-07-22 |
2022-01-27 |
John K. Jackson |
Silver enhanced cannabinoid antibiotics
|
|
WO2022043961A1
(en)
*
|
2020-08-31 |
2022-03-03 |
Nelson Mandela University |
Cannabinoid combinations and their use in the treatment of cancer
|
|
GB202013765D0
(en)
|
2020-09-02 |
2020-10-14 |
Gw Res Ltd |
Method of preparing cannabinoids
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
US20240041902A1
(en)
*
|
2020-12-08 |
2024-02-08 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Compositions and methods for the treatment of urothelial cancer
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
US20240108583A1
(en)
*
|
2021-01-25 |
2024-04-04 |
LDN Pharma Limited |
Naltrexone compositions
|
|
IL307444A
(en)
*
|
2021-04-05 |
2023-12-01 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Preparations and methods for the treatment of cancer
|
|
US12029720B2
(en)
|
2021-04-29 |
2024-07-09 |
Tilray Brands, Inc. |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
KR20240116463A
(ko)
|
2021-10-26 |
2024-07-29 |
더 유니버시티 오브 뉴캐슬 |
대마 추출물을 이용한 자궁내막증 및 기타 비암성 부인과 장애의 치료 방법
|
|
CA3235077A1
(en)
|
2021-10-26 |
2023-05-04 |
Alex Nance |
Systems and methods for producing hemp extracts and compositions
|
|
KR20240121723A
(ko)
|
2021-10-26 |
2024-08-09 |
에코파이버 유에스에이 인코포레이티드 |
대마 추출물을 사용하여 자궁내막암을 치료하는 방법
|
|
US12599617B2
(en)
|
2021-10-26 |
2026-04-14 |
Dove Innovation Pty Limited |
Methods of treating head and neck cancers with hemp extract
|
|
WO2023130161A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Dolce Cann Global Pty Ltd |
Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent
|
|
WO2023130160A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Dolce Cann Global Pty Ltd |
Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda).
|
|
US12440454B2
(en)
|
2022-02-01 |
2025-10-14 |
Portland Technology Holdings Llc |
Pharmaceutical compositions containing hemp extract for administration to felines and related methods
|
|
WO2023161921A2
(en)
*
|
2022-02-23 |
2023-08-31 |
Cannabotech Ltd. |
Compositions for use as an adjunctive therapy in the treatment of breast cancer
|
|
WO2023239415A1
(en)
*
|
2022-06-08 |
2023-12-14 |
Angrow Company Limited |
Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject
|
|
WO2023238114A1
(en)
*
|
2022-06-08 |
2023-12-14 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) |
Combinations and methods for the treatment of cancer
|
|
EP4568702A1
(en)
|
2022-08-12 |
2025-06-18 |
Jazz Pharmaceuticals Research UK Limited |
Oral solid dosage forms comprising cannabinoids
|
|
WO2024082014A1
(en)
*
|
2022-10-21 |
2024-04-25 |
Dolce Cann Global Pty Ltd |
Compositions comprising cannabidiolic acid and fatty acids
|
|
IL320518A
(en)
|
2022-10-26 |
2025-06-01 |
Ecofibre Usa Inc |
Stabilized compositions containing cannabidiol
|
|
IL320517A
(en)
|
2022-10-26 |
2025-06-01 |
Ecofibre Usa Inc |
Methods for treating estrogen-sensitive diseases with cannabis extract
|
|
CN115583933B
(zh)
*
|
2022-10-31 |
2024-02-06 |
暨明医药科技（苏州）有限公司 |
一种高纯度四氢大麻素同系物的制备方法
|